Duality Advisers’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-13,522
| Closed | -$3.11M | – | 511 |
|
|
2024
Q1 | $3.11M | Sell |
13,522
-2,120
| -14% | -$487K | 0.31% | 104 |
|
|
2023
Q4 | $3.44M | Buy |
15,642
+5,622
| +56% | +$1.24M | 0.36% | 74 |
|
|
2023
Q3 | $2.26M | Sell |
10,020
-864
| -8% | -$195K | 0.27% | 131 |
|
|
2023
Q2 | $2.4M | Buy |
10,884
+2,412
| +28% | +$532K | 0.3% | 121 |
|
|
2023
Q1 | $1.9M | Buy |
+8,472
| New | +$1.9M | 0.21% | 174 |
|
|
2022
Q2 | – | Sell |
-10,458
| Closed | -$1.88M | – | 872 |
|
|
2022
Q1 | $1.88M | Buy |
10,458
+8,842
| +547% | +$1.59M | 0.2% | 173 |
|
|
2021
Q4 | $349K | Sell |
1,616
-16,122
| -91% | -$3.48M | 0.04% | 431 |
|
|
2021
Q3 | $3.27M | Buy |
17,738
+15,770
| +801% | +$2.91M | 0.25% | 158 |
|
|
2021
Q2 | $353K | Sell |
1,968
-498
| -20% | -$89.3K | 0.03% | 465 |
|
|
2021
Q1 | $412K | Sell |
2,466
-4,125
| -63% | -$689K | 0.04% | 465 |
|
|
2020
Q4 | $1M | Sell |
6,591
-5,599
| -46% | -$849K | 0.07% | 344 |
|
|
2020
Q3 | $1.23M | Buy |
+12,190
| New | +$1.23M | 0.08% | 322 |
|